Trial intelligence / Profile preview

Bioequivalence of levetiracetam 1000 mg in healthy Thai volunteers under fasting conditions

TCTR20180405001Not yet recruiting

Sponsor
All Research
Start
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of levetiracetam (2 arms), sponsored by All Research. Primary endpoints: Cmax at 48 hours, AUC0-t at 48 hours and 1 more. Planned start Jun 2018; status: not yet recruiting.

02

Drugs

levetiracetam

Beyond the preview

Go deeper on TCTR20180405001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180405001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call